1. Home
  2. WETH vs PASG Comparison

WETH vs PASG Comparison

Compare WETH & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WETH

Wetouch Technology Inc.

SELL

Current Price

$0.98

Market Cap

16.9M

Sector

N/A

ML Signal

SELL

Logo Passage Bio Inc.

PASG

Passage Bio Inc.

HOLD

Current Price

$3.66

Market Cap

14.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WETH
PASG
Founded
1992
2017
Country
China
United States
Employees
N/A
27
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.9M
14.6M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
WETH
PASG
Price
$0.98
$3.66
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $15.50
AVG Volume (30 Days)
★ 72.8K
20.4K
Earning Date
11-11-2026
11-09-2026
Dividend Yield
★ 4.08%
N/A
EPS Growth
★ 15.38
N/A
EPS
★ 0.50
N/A
Revenue
★ $45,136,818.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1.96
★ N/A
Revenue Growth
★ 6.76
N/A
52 Week Low
$0.91
$3.29
52 Week High
$3.68
$20.00

Technical Indicators

Market Signals
Indicator
WETH
PASG
Relative Strength Index (RSI) 41.26 37.79
Support Level $0.96 $3.29
Resistance Level $1.27 $5.04
Average True Range (ATR) 0.07 0.39
MACD 0.00 -0.07
Stochastic Oscillator 44.61 2.55

Price Performance

Historical Comparison
WETH
PASG

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a business of research and development, manufacturing, and distribution of touchscreen displays to customers both in the PRC and overseas. The touchscreen products, which are manufactured by the Company, are mainly for use in financial terminals, automotive, Point of Sales, gaming, lottery, medical, Human-Machine Interface (HMI), and other specialized industries. The company sells touchscreen products both domestically in China and internationally, covering areas in Mainland China, including but not limited to the eastern, southern, northern, and southwest regions of Mainland China, Taiwan, South Korea, Germany, and other countries.

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

Share on Social Networks: